Procainamide
Procainamide is an antiarrhythmic drug used to treat cardiac arrhythmias. It induces rapid blockade of batfish toxin (BTX)-activated sodium channels in the myocardium and acts as a long-gated closure antagonist. Procainamide is metabolized through different pathways. The most common one is the acetylation of procainamide to the less toxic N-acetyl procainamide. Procainamide was approved by the US FDA on June 2, 1950.
Mouse Anti-Procainamide Antibody (MOFAB-081W) (CAT#: MOFAB-081W)
-
- Host species: Mouse
- Application: ELISA
- Protein: Procainamide
- Size: 0.5mg, 100µg
- Conjugate: None
- Alternative Names: Procainamide, Procainamide
Mouse Anti-Procainamide Antibody (MOFAB-082W) (CAT#: MOFAB-082W)
-
- Host species: Mouse
- Application: ELISA
- Protein: Procainamide
- Size: 0.5mg, 100µg
- Conjugate: None
- Alternative Names: Procainamide, Procainamide
Mouse Anti-Procainamide Antibody (MOFAB-083W) (CAT#: MOFAB-083W)
-
- Host species: Mouse
- Application: ELISA
- Protein: Procainamide
- Size: 0.5mg, 100µg
- Conjugate: None
- Alternative Names: Procainamide, Procainamide
For Research Use Only | Not For Clinical Use.
